Filing Details
- Accession Number:
- 0001567619-22-013995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-13 19:06:38
- Reporting Period:
- 2022-07-11
- Accepted Time:
- 2022-07-13 19:06:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1746473 | Pliant Therapeutics Inc. | PLRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1614741 | Eric Lefebvre | C/O Pliant Therapeutics, Inc. 260 Littlefield Avenue South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-11 | 3,000 | $20.00 | 138,436 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2020.
- Includes 4,356 shares of Common Stock acquired by the reporting person pursuant to an employee stock purchase program.
Billionaire Hedge Funds
